Smith & Nephew plc (SN.L)

1.021,00 -0,50 (-0,05%) Börsenschluss: 04:45PM GMT

Smith & Nephew plc

Building 5
Croxley Park Hatters Lane
Watford WD18 8YE
United Kingdom
44 1923 477 100
https://www.smith-nephew.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 19.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Deepak S. Nath Ph.D.	CEO & Director	4,71M	N/A	1972
Ms. Anne-Francoise Nesmes	CFO & Executive Director	1,07M	N/A	1972
Mr. Paul Connolly	President of Global Operations	N/A	N/A	1968
Mr. Andrew Swift	Vice President of Investor Relations	N/A	N/A	N/A
Ms. Helen Barraclough	Group General Counsel & Company Secretary	N/A	N/A	1980
Ms. Alison Parkes	Chief Compliance Officer & Compliance APAC	N/A	N/A	1973
Mr. Joe Metzger	Senior Vice President of Marketing Services & Communications	N/A	N/A	N/A
Mr. Philip G. Cowdy	Chief Corporate Development & Corporate Affairs Officer	N/A	N/A	1967
Ms. Elga Lohler	Chief Human Resources Officer	N/A	N/A	1968
Mr. Bradley Cannon	President of Global Orthopaedics	N/A	N/A	1968

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.

Beschreibung

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Corporate Governance

Smith & Nephew plcs ISS Governance QualityScore, Stand 28. November 2023, lautet 4. Die grundlegenden Scores sind Audit: 8, Vorstand: 2, Shareholderrechte: 1, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.